TWO-WAY COMMUNICATION IN A MEDICAL DEVICE

Abstract

A system is provided for delivering continuous positive airway pressure therapy. The system includes a flow generator, a sensor, and a computer. The computer is configured to control the operation of the flow generator based on sensor data. The computer is further configured to display, on a display device, one or more questions relating to demographic and / or subjective feedback; in response to the display of one or more questions, receive one or more inputs indicating answers to the one or more questions; transmit the answers to a remote processing system; receive, from the remote processing system, adjustments determined based on the transmitted answers; and adjust the system's control settings based on the received adjustments.

Description

This application claims priority to the United States provisional application No. 62 / 848,991, filed on May 16, 2019, the contents of which are incorporated herein in their entirety by reference. BACKGROUND OF THE TECHNOLOGY 2.1 FIELD OF TECHNOLOGY This technology refers to the detection, diagnosis, monitoring, treatment, prevention, and improvement of respiratory disorders. It also refers to medical devices and their use, and more specifically to methods and systems for configuring medical devices and providing tailored training and / or personalized therapy for patients using them. 2.2 DESCRIPTION OF THE RELATED TECHNIQUE 2.2.1 Human respiratory system and its disorders The body's respiratory system facilitates gas exchange. The nose and mouth form the entrance to a patient's airways. The airways consist of a series of branching tubes that become narrower, shorter, and more numerous as they penetrate deeper into the lungs. The primary function of the lungs is gas exchange, allowing oxygen to pass from inhaled air into the venous blood and carbon dioxide to move in the opposite direction. The trachea divides into the right and left main bronchi, which then further divide into terminal bronchioles. The bronchi are the conducting airways and do not participate in gas exchange. Further divisions of the airways lead to the respiratory bronchioles and, ultimately, to the alveoli. The alveolar region of the lung is where gas exchange occurs and is known as the respiratory zone. See “Respiratory Physiology,” by John B. West, Lippincott Williams & Wilkins, 9th edition, published in 2012. There are a variety of respiratory disorders. Some conditions can be characterized by particular features, for example, apneas, hypopneas, and hyperpneas. Examples of respiratory disorders include obstructive sleep apnea (OSA), Cheyne-Stokes respiration (CSR), respiratory failure, obesity hypoventilation syndrome (OHSS), chronic obstructive pulmonary disease (COPD), neuromuscular disease (NMD), and chest wall disorders. 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ i Obstructive sleep apnea (OSA), a form of sleep-disordered breathing (SDB), is characterized by events including the occlusion or obstruction of airflow through the upper airway during sleep. It results from a combination of an abnormally small upper airway and the normal loss of muscle tone in the region of the tongue, soft palate, and posterior oropharyngeal wall during sleep. The condition causes the affected individual to stop breathing for periods typically lasting between 30 and 120 seconds, sometimes 200 to 300 times per night. It often causes excessive daytime sleepiness and can lead to cardiovascular disease and brain damage. The syndrome is a common disorder, particularly in overweight, middle-aged men, although the affected person may be unaware of the problem. See U.S. Patent 4,944,310 (Sullivan). Cheyne-Stokes respiration (CSR) is another form of sleep-related breathing. CSR is a disturbance of a patient's respiratory control characterized by periodic oscillations in respiratory rate with increases and decreases in ventilation, known as CSR cycles. CSR is characterized by deoxygenation and reoxygenation of arterial blood. CSR may cause damage due to repeated hypoxia. In some patients, CSR is associated with a repeated state of arousal during sleep, resulting in severe sleep disturbance, increased sympathetic activity, and increased afterload. See U.S. Patent No. 6,532,959 (Berthon-Jones). Respiratory failure is a general term for breathing disorders in which the lungs cannot inhale enough oxygen or exhale enough CO2 to meet a patient's needs. Respiratory failure can encompass some or all of the following disorders. A patient with respiratory failure (a form of respiratory failure) may experience abnormal difficulty breathing while exercising. Obesity hypoventilation syndrome (OHSS) is defined as the combination of severe obesity and chronic daytime hypercapnia, in the absence of other known causes of hypoventilation. Symptoms include dyspnea, morning headache, and excessive daytime sleepiness. Chronic obstructive pulmonary disease (COPD) encompasses a group of lower airway diseases that share certain characteristics. These include increased resistance to airflow, a prolonged expiratory phase of breathing, and loss of normal lung elasticity. Emphysema and chronic bronchitis are examples of COPD. COPD is caused by chronic smoking (the primary risk factor), occupational exposures, air pollution, and genetic factors. Symptoms include exertional shortness of breath, chronic cough, and sputum production. Neuromuscular disease (NMD) is a broad term that encompasses many diseases and conditions that affect muscle function, either directly through muscle pathology 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ intrinsically or indirectly through nerve pathology. Some patients with NMD are characterized by progressive muscle deterioration leading to loss of ambulation, wheelchair dependence, difficulty swallowing, respiratory muscle weakness, and ultimately, death from respiratory failure.Neuromuscular disorders can be classified as rapidly progressive and slowly progressive: (i) Rapidly progressive disorders: These are characterized by muscle deterioration that worsens over months and leads to death within a few years (e.g., amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy (DMD) in adolescents); (ii) Variable or slowly progressive disorders: These are characterized by muscle deterioration that worsens over years and only slightly reduces life expectancy (e.g., shoulder or pelvic girdle muscular dystrophy, facioscapulohumeral muscular dystrophy, and myotonic muscular dystrophy). Symptoms of respiratory failure in neuromuscular disorders include: increased generalized weakness, dysphagia, dyspnea on exertion and at rest, fatigue, drowsiness, morning headache, difficulty concentrating, and mood changes. Chest wall disorders are a group of thoracic deformities that result in ineffective coupling between the respiratory muscles and the rib cage. These disorders are generally characterized by a restrictive defect and share the potential for long-term hypercapnic respiratory failure. Scoliosis and / or kyphoscoliosis can cause severe respiratory failure. Symptoms of respiratory failure include exertional dyspnea, peripheral edema, orthopnea, recurrent chest infections, morning headaches, fatigue, poor sleep quality, and loss of appetite. A range of therapies has been used to treat or improve these disorders. Healthy individuals can also benefit from these therapies to prevent respiratory problems from developing. However, these therapies do have some drawbacks. 2.2.2 Therapy Various therapies, such as continuous positive airway pressure (CPAP) therapy, non-invasive ventilation (NIV), and invasive ventilation (IV), have been used to treat one or more of the aforementioned disorders. Continuous positive airway pressure (CPAP) therapy has been used to treat obstructive sleep apnea (OSA). The mechanism of action involves the continuous positive airway pressure acting as a pneumatic splint, preventing upper airway obstruction by pushing the soft palate and tongue forward and away from the posterior oropharyngeal wall. Treatment of OSA with CPAP therapy can be voluntary, and therefore patients may choose not to adhere to the therapy if they find the devices used to administer it uncomfortable, difficult to use, expensive, or aesthetically unappealing. 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ Non-invasive ventilation (NIV) provides ventilatory support to a patient through the upper airway to help the patient breathe and / or maintain adequate oxygen levels in the body by performing all or part of the work of breathing. Ventilatory support is delivered through a non-invasive patient interface. NIV has been used to treat respiratory failure and respiratory distress syndrome (RDS), including conditions such as obstructive sleep apnea (OSA), chronic obstructive pulmonary disease (COPD), diabetic macular degeneration (DMD), and chest wall syndrome. In some cases, it can improve the comfort and effectiveness of these therapies. Invasive ventilation (IV) provides ventilatory support to patients who can no longer breathe effectively and can be delivered via a tracheostomy tube. In some ways, the comfort and effectiveness of these therapies can be improved. 2.2.3 Treatment systems These therapies can be delivered through a treatment system or device. Such systems and devices can also be used to detect, diagnose, or monitor a disorder without treating it. A treatment system may comprise a respiratory pressure therapy device (RPT device), an air circuit, a humidifier, a patient interface, and data management. 2.2.3.1 Patient Interface A patient interface can be used to connect respiratory equipment to its user, for example, by delivering air to an airway. The airflow can be delivered through a mask to the nose and / or mouth, a tube to the mouth, or a tracheostomy tube to the patient's trachea. Depending on the therapy being administered, the patient interface may form a seal, for example, with a region of the patient's face, to facilitate gas delivery at a pressure sufficiently different from ambient pressure to provide the therapy—for example, a positive pressure of approximately 10 cmHW relative to ambient pressure. For other forms of therapy, such as oxygen delivery, the patient interface may not provide a sufficient seal to facilitate airway delivery of gas at a positive pressure of approximately 10 cmHW. Designing a patient interface presents several challenges. The face has a complex three-dimensional shape. The size and shape of noses and heads vary considerably among individuals. Because the head includes bone, cartilage, and soft tissue, different regions of the face respond differently to mechanical forces. The jaw can move in relation to other skull bones. The entire head may move during respiratory therapy. As a result of these issues, some masks can be obstructive, aesthetically undesirable, expensive, not fit well, are difficult to use, and uncomfortable, especially when used for extended periods or when a patient is unfamiliar with the system. CPAP therapy is highly effective for treating some respiratory disorders, provided patients adhere to the therapy. If a mask is uncomfortable, the wrong size, difficult to use, poorly fitted to a particular patient's characteristics (for example, a nasal mask for a mouth breather), or difficult to clean (for example, difficult to assemble or disassemble), a patient may not adhere to the therapy. 2.2.3.2 Device for Respiratory Pressure Therapy (RPT) A respiratory pressure therapy (RPT) device can be used, individually or as part of a system, to deliver one or more of the therapies described above, such as by generating an airflow for delivery to an airway interface. The airflow can be pressurized. Examples of RPT devices include a CPAP device and a ventilator. Air pressure generators are common in a range of applications, such as industrial-scale ventilation systems. However, air pressure generators for medical applications have specific requirements that are not met by more general-purpose air pressure generators, such as reliability, size, and weight requirements for medical devices. Furthermore, even devices designed for medical treatment may have drawbacks related to one or more of the following: comfort, noise, ease of use, effectiveness, size, weight, manufacturability, cost, and reliability. RPT devices typically comprise a pressure generator, such as a motor-driven blower or a compressed gas tank, and are configured to deliver a flow of air to a patient's airway. In some cases, the airflow can be delivered to the patient's airway at positive pressure. The RPT device's outlet is connected via an air circuit to a patient interface, as described above. The device designer may be presented with an infinite number of options to choose from. Design criteria often conflict, meaning that some design choices are far from routine or unavoidable. Furthermore, the comfort and effectiveness of certain aspects can be highly sensitive to small, subtle changes in one or more parameters. 2.2.3.3 Humidifier Administering unhumidified air can cause airway drying. Using a humidifier with a respiratory therapy device and patient interface produces humidified gas, minimizing nasal mucosal drying and increasing patient airway comfort. Additionally, in colder climates, warm air applied to the face at and around the patient interface is generally more comfortable than cool air. 7ϠI I ϠΠ / 77Ϡ7 / □ / Yl· 2.2.3.4 Data Management There may be clinical reasons to collect data to determine whether a patient prescribed respiratory therapy has adhered to their prescribed treatment, for example, whether the patient has used their respiratory therapy device in accordance with one or more adherence standards. An example of an adherence standard for CPAP therapy is that a patient, to be considered adherent, must use the respiratory therapy device for at least four hours during the night for at least 21 out of 30 consecutive days. To determine a patient's adherence, a respiratory therapy device provider, such as a healthcare professional, can manually collect data by describing the patient's therapy regimen using the respiratory therapy device, calculate usage over a specified period, and compare it to the adherence standard.Once the healthcare professional has determined that the patient has used their RPT device in accordance with the compliance standard, the healthcare professional may notify a third party that the patient has complied. There may be other aspects of a patient's therapy that would benefit from communicating therapeutic data to a third party or an external system. Existing processes for communicating and managing such data can be costly, time-consuming, and prone to error. BRIEF OVERVIEW OF TECHNOLOGY The present technology is aimed at providing medical devices used in the detection, diagnosis, monitoring, improvement, treatment or prevention of respiratory disorders that have one or more of greater comfort, lower cost, greater effectiveness, ease of use and manufacturability. A first aspect of the present technology relates to a device used in the detection, diagnosis, monitoring, improvement, treatment, or prevention of a respiratory disorder. Another aspect of this technology relates to the methods used in the detection, diagnosis, monitoring, improvement, treatment, or prevention of a respiratory disorder. One aspect of some forms of this technology is to provide methods and / or a device to improve patient compliance with respiratory therapy. One form of the present technology comprises a respiratory pressure therapy system configured to present a patient with demographic and / or subjective questions and receive the answers to the questions so that they can be analyzed to determine adjustments to the respiratory pressure therapy system. 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ Another aspect of this technology is, for example, through advanced analytics, determining tailored training programs and / or personalized therapy for a patient based on the patient's responses to demographic and / or subjective questions and / or data from a plurality of other users. One form of the present technology involves applying adjustments to a respiratory pressure therapy system based on demographic and / or subjective questions answered by a patient. Another aspect of this technology is to present demographic and / or subjective questions and receive responses through a web or mobile application. Another aspect of this technology is to receive answers to demographic and / or subjective questions through a web or mobile application and use the answers to determine adjustments to the respiratory pressure therapy system. Another aspect of one form of the present technology is a processing system that includes a memory that stores a plurality of demographic and / or objective questions and a computer system configured to: transmit demographic and / or objective questions to a medical device and / or a mobile device configured to run an application to communicate with the medical device, receive answers to the questions from the medical device and / or the mobile device, and determine, for example, through advanced analysis, based on the answers received, a tailored training program for the patient and / or personalized therapy using the medical device. One aspect of some forms of present technology is a medical device that is easy to use, for example, by a person who has no medical training, by a person who has limited dexterity or vision, or by a person with limited experience in using this type of medical device. Another aspect of the present technology relates to a respiratory pressure therapy (RPT) system for providing continuous positive airway pressure (CPAP) to a patient. The system comprises: a flow generator configured to generate a supply of breathable gas for delivery to the patient, wherein the breathable gas exits the flow generator at a pressure level above atmospheric pressure; at least one sensor configured to measure a physical quantity while the breathable gas is being delivered to the patient; and a computing device including memory and at least one hardware processor.The computer device may be configured to: receive, from at least one sensor, sensor data that is based on the measured physical property of the breathing gas supply; control, based on the sensor data received, the flow generator to adjust a property of the breathing gas supply delivered to the patient; display, on a display device, one or more questions related to demographic and / or subjective feedback; in response to the. 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ display of one or more questions, receive one or more inputs indicating the answers to the one or more questions; transmit the answers to a remote processing system; receive, from the remote processing system, the respiratory pressure therapy system settings determined on the basis of the transmitted answers; and adjust, on the basis of the received settings, the control settings of the respiratory pressure therapy system.In some examples, (a) the remote processing system may be an on-demand cloud computing platform configured to perform machine learning using data received from a plurality of patients, (b) the questions may be pre-stored in memory, (c) the computing device may be further configured to perform configuration operations, and one or more questions may be displayed after configuration and after a predetermined condition is met, (d) the predetermined condition may include a predetermined amount of time that elapses after configuration, (e) the questions may include at least one question relating to the patient's demographic information and at least one question relating to the patient's subjective opinion on the use of the respiratory pressure therapy system,(f) the system may further include the remote processing system and the remote processing system may be configured to determine personalized training programs for the patient based on the responses transmitted to the remote processing system; (h) one or more questions may be received from the remote processing system; (i) the system may further include a patient interface configured to connect to at least one of the patient's airways and deliver breathable gas to the patient; and / or (j) the settings for the respiratory pressure therapy system and / or the personalized training programs are received by an application, website, email, and / or mobile device associated with the patient. Another aspect of the present technology relates to a device for treating a respiratory disorder in a patient. The device comprises: a display device; a pressure generator configured to generate an airflow to treat the respiratory disorder; a transducer configured to generate a flow signal representing a property of the airflow; and a controller, coupled to the display, the pressure generator, and the transducer.The controller can be configured to: receive the flow signal from the transducer; based on the received flow signal, control the pressure generator to adjust an airflow property; display, on the display device, a request for demographic and / or subjective feedback; in response to the request, receive one or more inputs representing the demographic and / or subjective feedback; transmit the demographic and / or subjective feedback data determined based on the one or more received inputs to a remote processing system; receive, from the remote processing system, the results of the analysis determined based on the transmitted demographic and / or subjective feedback data; and adjust, based on the received analysis results, the control settings of the device. 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ In examples, (a) the controller, display, and pressure generator may be housed in a common unit, (b) the adjusted control configuration may include a treatment pressure delivered to a patient mask connected to the pressure generator, (c) the analysis results may include customized training programs for the patient, (d) the analysis results may include customized therapy for the patient, (e) the controller may be configured to transmit, along with demographic and / or subjective feedback data, operational data of the device, and the analysis results may be determined based on the demographic and / or subjective data and the operational data of the device.(f) the request for demographic and / or subjective feedback may be displayed after a predetermined condition is met, (g) the predetermined condition may be a predetermined period of time after the device is set up, and / or (h) the predetermined condition may be a predetermined period of time in which the device has been operated by the patient. Another aspect of the present technology is directed to a method of operating a respiratory treatment device to generate an airflow in order to treat a respiratory disorder.The method comprises: measuring an airflow property using a transducer; calculating, in a controller and based on the measured property, a result comprising at least one of: a respiratory event, a cardiorespiratory characteristic of a patient, and a physiological state of the patient; controlling, in the controller, an adjustment of an airflow property based on the result; displaying one or more questions relating to demographic and / or subjective feedback; in response to the display of one or more questions, receiving, in the controller, one or more inputs indicating answers to the one or more questions; transmitting the answers to a remote processing system; and receiving, from the remote processing system, adjustments for the operation of the respiratory treatment device and / or personalized training programs for the patient based on the answers transmitted to the remote processing system. In the examples, (a) the method may include adjusting, based on the received settings, the control settings of the respiratory treatment device, (b) the settings for the operation of the respiratory treatment device may provide personalized therapy for the patient determined based on the responses transmitted to the remote processing system and the control settings of the respiratory treatment device at the time the inputs indicating the responses are received, (c) the questions may be displayed on a screen of the respiratory treatment device, (d) the questions may be displayed on a mobile device configured to run an application to control the respiratory treatment device, (e) the questions may be displayed after a predetermined condition is met,(f) the default condition may be a predetermined period of time after the respiratory treatment device is set up, and / or (g) the default condition may be a predetermined period of time in which the respiratory treatment device has been operated by the patient. 7ϠI I ϠΠ / 77Ϡ7 / □ / Yl· Another aspect of the present technology is directed to a processing system comprising: a memory that stores a plurality of demographic questions and a plurality of objective questions; a computer system that includes at least one hardware processor coupled to the memory, the computer system configured to: transmit, to a medical device associated with a patient, at least one demographic question and at least one objective question stored in the memory; receive, from the medical device, the answers to the at least one demographic question and at least one objective question transmitted to the medical device; transmit, to a mobile device configured to run an application to communicate with the medical device, a notification indicating that there are unanswered questions;to receive, from the mobile device, a request for questions in response to the request; to transmit, to the mobile device, at least one demographic question and at least one objective question stored in memory; to receive, from the mobile device, the answers to the at least one demographic question and at least one objective question transmitted to the mobile device; and to perform advanced analyses to determine, based on (1) the answers received from the medical device and the mobile device and (2) the answers received from a plurality of other medical devices, a tailored training program for the patient and personalized therapy using the medical device. In some examples, (a) the computer system may be configured to receive, from the medical device, responses to questions pre-stored on and answered by the medical device, (b) the medical device may be a respiratory therapy device, (c) the questions may be transmitted to the mobile device and / or the medical device after a predetermined condition is met, (d) the predetermined condition may be a predetermined time period after the medical device is configured, and / or (e) the predetermined condition may be a predetermined time period during which the medical device has been operated by the patient. The methods, systems, devices, and apparatus described can be implemented to enhance the functionality of a processor, such as a computer processor for a specific purpose, a respiratory monitor, and / or a respiratory therapy device.Furthermore, the methods, systems, devices, and apparatus described can provide improvements in the technological field of automated management, monitoring, and / or treatment of respiratory disorders, including, for example, sleep-related breathing disorders. Of course, some parts of the aspects may form secondary aspects of the current technology. Furthermore, several of the secondary aspects and / or aspects can be combined in various ways and also constitute additional or secondary aspects of the current technology. Other features of the technology will become evident from consideration of the information contained in the following detailed description, summary, graphics, and claims. zhl Lnn / zznz / q / Yi BRIEF DESCRIPTION OF THE GRAPHICS The present technology is illustrated by way of example, and not as a limitation, in the figures in the accompanying charts, in which the same reference numbers refer to similar elements, including: 4.1 TREATMENT SYSTEMS Figure 1A shows a system including a patient 1000 using a patient interface 3000 in the form of nasal cushions, which receives a positive pressure air supply from a respiratory therapy device 4000. The air from the respiratory therapy device 4000 is humidified in a humidifier 5000 and passes along an air circuit 4170 to patient 1000. A bed mate 1100 is also shown. The patient is sleeping in a supine position. Figure 1B shows a system that includes a patient 1000 using a patient interface 3000 in the form of a nasal mask, which receives a positive pressure air supply from a PRT device 4000. The air from the PRT device is humidified in a humidifier 5000 and passes along an air circuit 4170 to patient 1000. Figure 1C shows a system that includes a patient 1000 using a patient interface 3000 in the form of a full-face mask, which receives a positive pressure air supply from a respiratory therapy device 4000. The air from the respiratory therapy device is humidified in a humidifier 5000 and passes along an air circuit 4170 to patient 1000. The patient is sleeping on their side. 4.2 RPT DEVICE Figure 4A shows an RPT device in accordance with one form of the present technology. Figure 4B shows a schematic diagram of the pneumatic pathway of a PRT device according to one aspect of the present technology. The upstream and downstream directions are indicated with reference to the blower and the patient interface. The blower is defined as being in the upstream direction of the patient interface, and the patient interface is defined as being in the downstream direction of the blower, regardless of the actual flow direction at any given time. Elements located in the pneumatic pathway between the blower and the patient interface are in the downstream direction of the blower and the upstream direction of the patient interface. Figure 4C shows a schematic diagram of the electrical components of an RPT device in accordance with a form of the present technology. 7ϠI I ϠΠ / 77Ϡ7 / □ / Yl· Figure 4D shows a schematic diagram of the electrical components of an RPT device in accordance with a form of the present technology. Figure 4E is a schematic diagram of the algorithms implemented on an RPT device in accordance with one form of the present technology. Figure 4F is a flowchart illustrating a method carried out by the motor therapy module of Figure 4E in accordance with a form of the present technology. Figure 4G shows a diagram of a communication system between an RPT device and a remote computer system according to one form of the present technology. Figure 4H shows exemplary operations performed by an RPT device and a remote computer system according to one form of the present technology. Figure 41 shows examples of display screens that include requests for demographic and / or subjective feedback that may be shown to a patient according to a form of the present technology. Figure 4J shows another example of operations performed by an RPT device and a remote computer system according to one form of the present technology. Figure 4K shows a data flow diagram in a system that provides communication between a medical device, an 8030 patient portal, and an 8010 patient survey service according to a form of the present technology. 4.3 HUMIDIFIER Figure 5A shows an isometric view of a humidifier in accordance with a form of the present technology. Figure 5B shows an isometric view of a humidifier according to a form of the present technology, showing a humidifier tank 5110 extracted from the humidifier tank reservoir 5130. Figure 5C shows a schematic view of a humidifier in accordance with a form of the present technology. zíu Lnn / zznz / q / YL DETAILED DESCRIPTION OF EXAMPLES OF THE TECHNOLOGY Before the present technology is described in more detail, it should be understood that the technology is not limited to the specific examples described in this disclosure, which may vary. It should also be understood that the terminology included in this disclosure is intended to describe only the specific examples discussed and is not intended to be exhaustive. The following description is provided in relation to several examples that may share one or more characteristics and / or functions. It should be understood that one or more characteristics of one example may be combined with one or more characteristics of another example or examples. Likewise, a single characteristic or combination of characteristics in any of the examples may constitute another example. 5.1 THERAPY In one form, the present technology comprises a method for treating a respiratory disorder that includes the step of applying positive pressure to the entrance of a patient's airways 1000. In some examples of the current technology, positive pressure air is delivered to the patient's nostrils through one or both nostrils. In some examples of current technology, mouth breathing is limited, restricted, or avoided. 5.2 TREATMENT SYSTEMS In one form, the present technology comprises an apparatus or device for treating a respiratory disorder. The apparatus or device may comprise an RPT 4000 device for delivering pressurized air to the patient 1000 through an air circuit 4170 to a patient interface 3000. 5.3 PATIENT INTERFACE A non-invasive patient interface 3000 according to one aspect of the present technology comprises one or more of the following functional aspects: a seal-forming structure, a plenum chamber, a positioning and stabilization structure, a vent, a connection port 3600 for connection to the air circuit 4170, and a front support. In some forms, one or more physical components may provide a functional aspect. In some forms, a single physical component may provide one or more functional aspects. In use, the seal-forming structure is arranged to surround an inlet to the patient's airway to facilitate the delivery of positive-pressure air to the airway. 7ϠI I ϠΠ / 77Ϡ7 / □ / Yl· If the patient interface cannot comfortably deliver a minimum level of positive airway pressure, the patient interface may be unsuitable for respiratory pressure therapy. The 3000 patient interface according to a form of the present technology is constructed and arranged to be able to provide an air supply at a positive pressure of at least 4 cmH2O with respect to ambient, at least 6 cmH2O with respect to ambient, at least 10 cmH2O with respect to ambient, at least 20 cmH2O with respect to ambient, at least 30 cmH2O with respect to ambient or any positive pressure between 4 cmH2O and 30 cmH2O with respect to ambient. 5.4 RPT DEVICE An RPT 4000 device conforming to one aspect of the present technology comprises mechanical, pneumatic, and / or electrical components and is configured to execute one or more 4300 algorithms, such as any of the methods described herein, in whole or in part. The RPT 4000 device can be configured to generate an airflow for delivery to a patient's airways to treat one or more respiratory conditions described herein. In one form, the RPT 4000 device is constructed and arranged to be able to supply an air flow in a range of -20 L / min to 150 L / min while maintaining a positive pressure of at least 6 cmH2O, or at least 10 cmH2O, or at least 20 cmH2O. The RPT device may have an external housing 4010, consisting of two parts: an upper part 4012 and a lower part 4014. In addition, the external housing 4010 may include one or more panels 4015. The RPT device 4000 comprises a chassis 4016 that supports one or more internal components of the RPT device 4000. The RPT device 4000 may include a handle 4018. The pneumatic pathway of the RPT 4000 device may include one or more air pathway elements, for example, an inlet air filter 4112, an inlet silencer 4122, a pressure generator 4140 capable of supplying positive pressure air (for example, a blower 4142 including a motor 4144), an outlet silencer 4124, and one or more transducers 4270, such as pressure sensors and flow sensors 4274. One or more of the airway elements can be housed in a removable unit structure called the pneumatic block 4020. The pneumatic block 4020 can be housed in the outer casing 4010. In one form, a pneumatic block 4020 is supported by or formed as part of the chassis 4016. The RPT 4000 device may have an electrical power supply 4210, one or more input devices 4220, a central controller 4230, a therapy device controller 4240, a pressure generator 4140, one or more protection circuits 4250, a memory 4260, transducers 4270, a data communication interface 4280, and one or more output devices 4290. Electrical components 4200 7PI I PI / 77PI7 / □ / Yl· can be mounted on a single 4202 printed circuit board (PCBA). Alternatively, the RPT 4000 device can include more than one 4202 PCBA. An RPT device may comprise one or more of the following components in a single unit. Alternatively, one or more of the following components may be located as separate units. For example, the RPT device may comprise one or more of the following: an air filter 4110, a side panel, a silencer (e.g., silencer 4120, inlet silencer 4122, outlet silencer 4124), a pressure generator, a pneumatic block, a chassis, a transducer 4270 (flow transducer, pressure transducer, motor speed transducer), a light sensor, a spill valve 4160, an air circuit, an air circuit connector, an oxygen supply port, a power supply, a central controller, a therapy device controller, a protection circuit, a data connection interface, memory, and output devices (e.g., a display, alarms, etc.).) and a user interface panel or panels, as described in PCT application PCT / AU2014 / 050426 (WO2015089582), which is incorporated herein by reference. According to one example, the user interface panel includes one or more 4220 input devices in the form of buttons, switches, or dials to enable user interaction with the device. The buttons, switches, or dials may be physical devices or software devices accessible via a touchscreen. The buttons, switches, or dials may be physically connected to the 4010 external housing or may communicate wirelessly with a receiver that is electrically connected to the 4230 central controller. In one way, the 4220 input device can be constructed and arranged to allow a person to select a value and / or a menu option. 5.4.1.1 Data communication systems In one form of the present technology, a data communication interface 4280 is provided, connected to the central controller 4230. The data communication interface 4280 can be connected to the remote external communication network 4282 and / or to a local external communication network 4284. The remote external communication network 4282 can be connected to a remote external device 4286. The local external communication network 4284 can be connected to a local external device 4288. In one form, the 4280 data communication interface is part of the 4230 central controller. In another form, the 4280 data communication interface is separate from the 4230 central controller and may comprise an integrated circuit or a processor. In one way, the 4282 remote external communication network is the Internet. The 4280 data communication interface can use wired communication (e.g., via Ethernet or fiber optics) or a wireless protocol (e.g., CDMA, GSM, LTE) to connect to the Internet. 7ϠI I ϠΠ / 77Ϡ7 / □ / Yl· In one way, the local external communication network 4284 uses one or more communication standards, such as Bluetooth, or an infrared communication protocol. In one form, the remote external device 4286 consists of one or more computers, for example, a group of networked computers. In another form, the remote external device 4286 may consist of virtual computers instead of physical computers. In either case, such a remote external device 4286 may be accessible by a duly authorized person, such as a clinician. The local external device 4288 can be a personal computer, a mobile phone, a tablet, or a remote control. 5.4.1.2 Output devices including optional display, alarms A 4290 output device conforming to this technology may take the form of one or more visual, audio, and touch units. A visual display may be a liquid crystal display (LCD) or a light-emitting diode (LED) display. 5.4.1.2.1 Display Controller A 4292 display controller takes as input the characters, symbols, or images that are to be displayed on the 4294 display and converts them into commands that cause the 4294 display to show those characters, symbols, or images. 5.4.1.2.2 Screen A 4294 display is configured to visually display characters, symbols, or images in response to commands received from the 4292 display controller. For example, the 4294 display might be an eight-segment display, in which case the 4292 display controller converts each character or symbol, such as the digit 0, into eight logic signals indicating whether the respective eight segments should be activated to display a particular character or symbol. 5.4.2 RPT Device Algorithms As mentioned earlier, in some forms of the current technology, the central controller may be configured to implement one or more 4300 algorithms expressed as computer programs stored on a non-transient, computer-readable storage medium, such as 4260 memory. The 4300 algorithms are generally grouped into sets called modules. The modules may include a preprocessing module 4310 that provides pressure compensation 4312, ventilation flow rate estimation 4314, leak flow rate estimation 4316, and respiratory flow rate estimation 4318. The processing module of The preprocessing algorithm 4310 can be used as input to a therapy motor module 4320. The therapy motor module 4320 comprises one or more of the following algorithms: a phase determination 4321, a waveform determination 4322, a ventilation determination 4323, an inspiratory flow limitation determination 4324, an apnea / hypopnea determination 4325, a snoring determination 4326, an airway patency determination 4327, a target ventilation determination 4328, and a therapy parameter determination 4329. A therapy controller 4330 receives as inputs the therapy parameters from the therapy parameter determination algorithm 4329 of the therapy motor module 4320 and controls the pressure generator 4140 to deliver a air flow in accordance with therapy parameters.In one form of the present technology, the central controller 4230 executes one or more methods for detecting fault conditions 4340. Details relating to one or more operations performed by the algorithms are described in PCT application PCT / AU2014 / 050426 (WO2015089582), which is incorporated herein by reference. 5.5 AIR CIRCUIT An air circuit 4170 in conformity with one aspect of the present technology is a duct or tube constructed and arranged in use to allow a flow of air to travel between two components, such as the RPT 4000 device and the patient interface 3000. Specifically, the 4170 air circuit can be seamlessly connected to the outlet of the 4020 pneumatic block and the patient interface. The air circuit may be referred to as the air line. In some cases, there may be separate limbs of the circuit for inhalation and exhalation. In other cases, a single limb is used. In some forms, the 4170 air circuit may comprise one or more heating elements configured to heat the air in the air circuit, for example, to maintain or raise the air temperature. The heating element may be in the form of a heated wire circuit and may comprise one or more transducers, such as temperature sensors. In one form, the heated wire circuit may be helically wound around the axis of the 4170 air circuit. The heating element may be in communication with a controller, such as a 4230 central controller. An example of a 4170 air circuit comprising a heated wire circuit is described in U.S. Patent No. 8,733,349, which is incorporated herein in its entirety by reference. 5.6 Two-way communication for personalized therapy and / or training In one form of current technology, a medical device (e.g., a remote processing device) may include bidirectional communication with one or more remote processing systems to facilitate 7P L iP / 77P7 / 3 / II customized training programs, personalized therapy, and / or targeted care. The medical device may be configured to capture data and / or transmit data to the remote processing system for processing. Captured data may include sensor data, demographic information, and / or subjective information. The remote processing system may perform patient segmentation and / or advanced analysis using the received data and provide the medical device with customized solutions. Customized solutions may include tailored training programs to increase engagement and motivation, personalized therapy with automated comfort updates and / or therapy settings to increase long-term adherence, and / or targeted care and follow-up based on knowledge of patients who need assistance.Patient segmentation and advanced analytics may include performing deep machine learning using data from other users and using one or more trained models to provide tailored solutions. Unlike conventional systems where a medical device's configuration had to be pre-loaded and modified by a highly trained technician, examples of this technology allow the medical device to be automatically configured after it is enabled for use. Device settings and patient recommendations can be accurately determined remotely and quickly without requiring a clinician to perform multiple iterations of modifying device settings before the patient feels comfortable using the device. Furthermore, the information received from the user and the device settings can be used to improve the settings of other medical devices and provide relevant recommendations to other patients. Figure 4G shows a diagram of a communication system between an RPT 4000 device and a remote computer system. Figure 4G includes one or more RPT 4000 devices associated with a patient 1000. This technology is not limited to the RPT device but can be applied to other medical devices. The RPT 4000 device can be configured to communicate via a data communication interface 4280 with a remote external device 4286 and / or local external devices 4288 (e.g., a personal computer, mobile phone, tablet, and / or remote control) and / or a remote external device. The local external devices 4288 can be configured to communicate directly with the RPT 4000 device when located in close proximity to the RPT 4000 device or remotely via a local or external network when the local external device 4288 is not located near the RPT 4000 device.The remote external device 4286 can be accessed by a duly authorized person, such as a clinician, device manufacturer, and / or supplier. As shown in Figure 4G, the RPT 4000 device can also communicate with a remote computing system that includes a 6030 server and / or a 6040 cloud computing platform (e.g., Amazon Web Services™, Google Cloud Platform™, Microsoft™ Azure). 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ One or more medical devices 6062 or 6064 (which may be RPT devices), associated with other patients 1002 and 1004, may be configured to communicate with the remote external device 4286, the server 6030 and / or the cloud computing platform 6040. The devices illustrated in Figure 4G can communicate via a communication link 6020 comprising a remote external communication network 4282 and / or a local external communication network 4284. The RPT 4000 device and / or the medical devices 6062 and 6064 can be configured to transmit sensor data, demographic and / or subjective feedback via the communication link 6020 to the server 6030 and / or the cloud computing platform 6040. The server 6030 and / or the cloud computing platform 6040 can be configured to perform patient segmentation and / or advanced analysis using the received data and provide the RPT devices with customized solutions. Customized solutions may include tailored training programs, personalized therapy, and / or targeted care. Figure 4H shows exemplary operations performed by an RPT 4000 device and a remote computer system according to one form of the present technology. Although Figure 4 shows the operations performed by specific devices, the operations shown are not so limited. One or more operations may be performed by other devices operatively coupled to the RPT 4000 device and / or the remote computer system. In some examples, one or more operations shown as being performed by the RPT 4000 device may be performed using a web or mobile application running on another device (for example, a local external 4288 device). The RPT 4000 device may be configured to perform RPT 4000 device setup (step 7010). Setup may include associating a patient with the RPT 4000 device, configuring the initial RPT 4000 device settings for the patient, and / or providing instructions on how to use the device. One or more operations disclosed in U.S. Provisional Application Ns62 / 749.430 filed October 23, 2018, entitled SYSTEMS AND METHODS FOR SETUP OF CPAP SYSTEMS, and U.S. Application Ns16 / 661.250 filed October 23, 2019, entitled SYSTEMS AND METHODS FOR SETUP OF CPAP SYSTEMS, each of which is incorporated herein by reference in its entirety, may be performed during RPT 4000 device setup. Configuration can be performed when the RPT 4000 device is first powered on after purchase or reset, or when the RPT 4000 device is assigned to a new patient. Configuration can be performed without user interaction by applying settings for the RPT 4000 device stored in memory (e.g., memory 4260 or external memory). 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ to the RPT 4000 device) or the receipt of instructions from a remote external device 5286 controlled by a clinician, device manufacturer and / or distributor. Patient input can be requested and received during setup from the RPT 4000 device and / or other devices. In some examples, instructions and / or questions can be provided using the 4290 output devices, and patient input can be received using the 4220 input devices. In other examples, only the RPT 4000 device can be used to receive input during setup. In still other examples, a local external 4288 device can be used, instead of or in addition to the RPT 4000 device, to receive user input for configuring the RPT 4000 device. Display screens can be generated on the RPT 4000 device and / or the external device to request patient input during device setup.In some examples, the RPT 4000 device and / or the external local 4288 device may receive audio instructions and / or audible feedback. In some examples, user-entered data and / or customized training programs, personalized therapy, and / or specific care and follow-up (e.g., provided in response to the entered data) may be delivered through a variety of different mechanisms (e.g., apps, web, email, telephone, etc.). The RPT 4000 device can be operated (step 7012) based on the device settings configured during setup. During operation, the RPT 4000 device's operation can be adjusted based on sensor data (e.g., flow sensor 4274, pressure sensor 4272, and / or velocity sensor 4276) and / or additional settings received from the patient and / or clinician. After one or more predetermined conditions are met, feedback requests can be displayed to the patient (step 7018). The feedback request can be displayed on screen 4294 or on the device and / or the local external device 4288 (for example, in an application). The feedback request can ask the user for demographic and subjective information in the form of a question or instruction. The feedback request can be made automatically when the predetermined condition is met. The feedback is not limited to demographic and subjective information and can include additional questions.Feedback, demographic and / or subjective, may include the outcome of the sleep study, symptoms, comorbidities or other health information, including the presence of other sleep problems (e.g., insomnia), level of knowledge about sleep apnea, level of comfort in approaching therapy, stage at which they are (new to therapy or experienced user), and / or motivation. The default condition may include the passage of a predetermined amount of time after the RPT 4000 device is set up, or the patient reaching a specific goal, such as using the device for a predetermined period of time (e.g., a preset number of 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ hours, days or weeks), the use of a specific function offered by the RPT 4000 device (e.g., operating the device in a low-power mode) a predetermined number of times or for a predetermined period of time, completing the configuration of the RPT 4000 device, receiving a signal from the remote computer system or clinician-operated device, receiving feedback requests from another device, having a flag set indicating that feedback requests are available to be displayed to the patient, and / or receiving notification that the feedback request is available for download. In response to the feedback request, inputs representing demographic and / or subjective patient feedback can be received (step 7020). These inputs can be received using only the RPT 4000 device (for example, via input devices 4220), only the local external device 4288, or both the RPT 4000 device and the local external device 4288. Figure 41 shows examples of display screens that include demographic and / or subjective feedback prompts that can be shown to a patient. The feedback prompts can be displayed on screen 4294 of the RPT 4000 device and / or on the screen associated with the local external device 4288. Although Figure 41 shows the display screens in a specific order, the implementation is not so restricted. One or more of the display screens can be provided in a different order or not included in the sequence. Alternatively, one or more display screens can be included in the sequence. The introductory screens 7050 and 7052 may include introductory text, graphics, and / or a video with information that introduces the patient to the system's customization features, components, and / or therapy. The introductory screen 7050 may be displayed for a predetermined period of time before automatically transitioning to the display screen 7052. The 7052 screen may provide selectable options for the user to continue responding to the displayed feedback request or to skip the RPT 4000 device customization feature. In some examples, instead of or in addition to skipping the customization feature, the user may have the option to provide the information later.The 7050 and / or 7052 introduction screens may be displayed only when the unit is first turned on by a user (for example, after purchasing the unit or after restarting it) or a predetermined number of times until the customized information is received. Screen 7054 displays an option for the patient to select their gender. As shown on screen 7054, the patient may be provided with a selectable option to skip the response request. One or more of the other feedback requests may also include an option to skip a response request. 7ϠI I ϠΠ / 77Ϡ7 / □ / Yl· Screen 7056 displays an option to enter the patient's age. In other examples, the information request may include entering the day, month, and / or year of the patient's birthday. Screen 7058 shows an option to enter the patient's height and screen 7060 shows an option to enter the patient's weight. Screen 7062 displays a question to determine if the patient has previously used the RPT 4000 device. In some examples, the question may include a number of other RPT devices the patient has used, or the level of experience the patient believes they have on a predetermined scale in using the RPT 4000 device. Screen 7064 displays a question asking the patient to rate their usual level of sleepiness during the day. The user has access to a variable scale ranging from not being sleepy to being very sleepy. Other subjective questions about sleep may include sleep regularity, sleep satisfaction, sleep alertness, sleep time, sleep efficiency, and / or sleep duration.Questions may include: Do you usually wake up at roughly the same time (within a margin of one hour) every day? How often are you satisfied with your sleep? How often are you able to stay awake all day without dozing or napping? Do you usually spend the period from 2 to 4 a.m. in the middle of your nighttime sleep? Are you usually awake for less than 39 minutes throughout the night? and / or Do you usually sleep between 6 and 8 hours a day? One or more of the answers to the questions may be provided with a sliding scale and / or a plurality of selectable responses (e.g., rarely, sometimes, and usually). In an example of this technology, feedback can include non-subjective feedback. This feedback can include an apnea-hypopnea index entered by the patient and / or retrieved from a database or from a physician or clinician. Based on the feedback results, the patient can be assigned a sleep score, training programs, and / or personalized therapy. This information can be determined by the RPT 4000 device and / or other devices (e.g., the devices shown in Figure 4G). The sleep score can be displayed to the patient and / or updated as additional patient information is received periodically. Other display screens may include additional feedback requests, such as how well the patient slept during the night, the comfort level of the mask, the comfort of breathing while using the CPAP, and / or the level of satisfaction with the device's performance. In some examples, subjective questions (e.g., sleep comfort) may be received multiple times, each for a different period of time. For example, the RPT device 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ The 4000 can be configured to ask a patient to provide information about sleep comfort for a predetermined number of days (e.g., seven days). Screens that request a response may include an option to select that the response is now known and / or provide an option to retrieve the information from an external source (e.g., a database, medical records, an external device, etc.). In some examples, a single feedback request may be displayed on the screen, or two or more feedback requests may be displayed simultaneously on a single screen. For example, the request to enter the patient's age and height may appear simultaneously on one screen. In one form of the present technology, display screens with feedback requests can be shown on a touch input screen. In one form of the present technology, inputs to the questions displayed on the screen can be entered using one or more 4220 input devices, including physical buttons, switches, or dials, or software devices accessible through the touch screen. In one form of the current technology, feedback requests can be audibly issued to the patient using speakers and / or verbal feedback responses can be captured through a microphone. After receiving responses to feedback requests, the responses can be stored in memory and / or transmitted (step 7022) to the remote computing system. In one form of the present technology, the data can be transmitted directly to an on-demand cloud computing platform (e.g., Amazon Web Services™, Google Cloud™, Microsoft™ Azure). The responses can include demographic and / or subjective data. In one form of the present technology, if the connection to the remote computing system is unavailable, the feedback data can be stored in memory 4260 until the connection is available. In step 7022, additional data can be transmitted along with the feedback data to the remote computer system. For example, this additional data may include therapy data to determine if the patient has used the RPT 4000 device according to the compliance rule, the RPT 4000 device identification information (e.g., serial number), the RPT 4000 device location information, user profile data, data captured by sensors (e.g., the 4270 transducer), settings applied during RPT 4000 device setup, the type of accessories attached to the RPT 4000 device, and / or any modifications made to the settings by the patient and / or when such modifications were made. The remote computing system receives the data (step 7024), analyzes the data (step 7026), and transmits the analysis results (step 7028) to the RPT 4000 device and / or the web or mobile application. The remote computing system can receive demographic and / or subjective feedback, and other data, from the RPT 4000 device or an external local device. The data can be received directly by the remote computing system for processing. The remote computing system may include a server (6030) and / or a cloud computing platform (6040). The server (6030) may be a non-cloud-based server managed by the manufacturer or the clinician. The remote computer system can segment patient data (e.g., age range, gender, weights, environment, etc.) and use models developed using similar and / or different data from other users to determine what the patient needs and / or what settings of the RPT 4000 device should be modified. The models may be predetermined by advanced analytics, artificial intelligence, and / or machine learning. The remote computer system may include models determined based on information about the operation of other RPT devices (e.g., medical devices 6062 and / or 6064) associated with other patients 1002 and / or 1004, and demographic and subjective information received from those other patients 1002 and / or 1004. Advanced analytics, artificial intelligence, and / or machine learning may be performed using data from a large number of patients, and the models may be updated with new data as new data becomes available (e.g., data including demographic comments, subjective comments, and / or changes in compliance rules). The results of the analysis may include tailored training programs, personalized therapy, and / or targeted care and follow-up. In response to the transmission of feedback data, the RPT 4000 device can receive the analysis results (step 7030) from the remote computer system. The analysis results may include customized training programs, personalized therapy, and / or targeted care and follow-up. Customized training programs can be provided to increase patient engagement and motivation. These programs may include instructions on how to use the device correctly, explain the benefits of using the device's features, and / or suggest other medical devices and / or accessories that may be beneficial to the patient. For example, information about an accessory (e.g., a different type of mask) that will enhance the patient's experience using the RPT 4000 device can be displayed on screen 4294 or on the local external device 4288. Personalized therapy can provide automatic comfort adjustments that have been shown to increase long-term adherence (LTA). Personalized therapy can be automatically applied to the RPT 4000 device without patient interaction. In some examples, the patient may receive 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ information about the changes in therapy and you are asked to accept the proposed changes before they are applied. Specific care and follow-up may include notifying the patient of the need for changes in care or the need to schedule a meeting with a clinician or other expert. For example, the RPT 4000 device and / or the external local device 4288 may be used to schedule and / or conduct a meeting with a clinician or other expert. The analysis results can be used to adjust the settings (step 7032) of the RPT 4000 device. Modifying the settings may include adjusting one or more comfort settings of the RPT 4000 device. For example, the analysis results may include instructions for modifying the pressure ramp settings, expiratory relief settings, humidity settings, and air temperature settings. In one form of the current technology, the analysis results may indicate that continued use of the RPT 4000 device is unsafe, and the device may be deactivated. Once the analysis results have been applied, the RPT 4000 device can be operated (step 7034). Applying the analysis results and operating the RPT 4000 device with the updated settings will allow it to control the device more effectively to meet patient needs. In some examples, modifications can be made to make the device operate more efficiently (for example, by using less energy or lowering the temperature of a heated air supply tube) without significantly compromising patient comfort. After a predetermined time, one or more of the previously made feedback requests and / or new feedback requests may be presented to the patient and receive responses (step 7036). The response may be used to determine whether the previously applied adjustments were effective and / or whether further changes to the operation and / or use of the RPT 4000 device are necessary. Additional feedback requests may be made periodically or when the remote computer system makes new feedback requests available. In some examples, the request for additional information may appear each time the user turns on the RPT 4000 device. When using the RPT 4000 device, the patient may be shown a sleep score and a daily overview (e.g., a daily recommendation that can be adjusted based on feedback from the patient and / or other patients). Providing this additional information may involve the user updating one or more previously provided data points (e.g., age, height, weight, and / or sleep information). zíu Lnn / zznz / q / YL In one form of the present technology, some feedback requests may be submitted on the RPT 4000 devices and other feedback requests may be submitted on the local external device 4288 or another medical device associated with the same patient 1000. Feedback requests submitted on one device may be marked as displayed and unsolicited on other devices. In one form of the present technology, operations related to the display of feedback requests and the receipt of inputs for feedback requests can be performed during the device setup (step 7010). Figure 4J shows another example of operations performed by an RPT 4000 device and a remote computer system. In the example illustrated in Figure 4H, the feedback request data was pre-stored in the RPT 4000 device. For example, the information request data may have been previously stored in memory by the manufacturer, distributor, or clinician. In the example illustrated in Figure 4J, the remote computer system transmits the feedback request data (step 7016). The RPT 4000 device receives the transmitted feedback request data (step 7014) from the remote computer system and uses the data to receive feedback from the patient.In some examples, the system that transmits the feedback request data may be a different system from the system that performs the analysis using the demographic and / or subjective feedback data transmitted from the RPT 4000 device. The remote computer system can transmit feedback request data in response to a request from the RPT 4000 device. In some examples, the remote computer system can send feedback request data to the RPT 4000 device at some predetermined time period, or ad hoc (either directly or via home medical equipment). The feedback request data can be entered by a physician or clinician. The physician or clinician may have a user interface to enter their own questions as part of the information request data. The physician or clinician may have a function to ask questions of their own patient through the RPT 4000 device or a device associated with the RPT 4000 device (for example, the local external device 4288). For example, the physician or clinician may enter the questions using the remote computer system. The physician or clinician may associate one or more of the questions with one or more conditions to distribute the questions to the RPT 4000 device. The conditions may include one or more patient characteristics, the type of device, and peripheral devices (for example, the type of mask, tubing, etc.).) connected to the RPT 4000 device, and / or the device's operating parameters. 7ϠI I ϠΠ / 77Ϡ7 / □ / Yl· Figure 4K shows a data flow diagram in a system that provides communication between a medical device (e.g., the RPT 4000 device), a patient portal 8030, and a patient survey service 8010. The 8010 Patient Survey Service can be deployed on one or more servers, including cloud and / or dedicated servers (e.g., the 6030 server). The 8010 Patient Survey Service can coordinate the management and communication of questions and responses for demographic and subjective feedback. As shown in Figure 4K, the 8010 Patient Survey Service can support sending questions to a patient account associated with a medical device. The patient account can be accessed via a web or mobile application running on a local 4288 device or via the RPT 4000 device. The patient account accessed via the web or mobile application can enable monitoring, reporting, and / or adjustment of the medical device, as well as patient education. The 8020 patient survey service can notify clients that questions are available. Questions can be made available when they are added (for example, through marketing) to a content management system. Questions can be retrieved from the 8020 patient survey service using GET requests. For example, a patient account accessed via the web or mobile app can call home and receive questions through the 8030 patient portal. Questions can be provided in JavaScript Object Notation (JSON) format, which represents the question content and possible answers. The question presentation can be embedded in the application as HTML content.The patient account accessed via the web or mobile application can send responses to the patient survey service 8020 via a proxy through the patient portal 8030 (e.g., via a POST instruction). The medical device can call home and retrieve questions via proxy through the MCS 8024 device and send the response to the Patient Survey Service 8020 via proxy through the MCS 8024 device (for example, via a POST instruction). GET calls can include a serial number from the medical device so that the Patient Survey Service 8010 can track which questions were sent to which device and / or application. In one aspect, the 8010 patient survey service can manage questions so that they are available on the patient portal after a predetermined period (e.g., 48 hours). This can minimize duplicate questions. In another aspect, the 8010 patient survey service can manage questions so that questions already answered by a patient are not displayed again. For example, the 8010 patient survey service can keep a record of the questions answered on a platform (by 7PI I PI / 77PI / □ / Yl· example, a medical device) and not display those questions in a patient's account accessed through a web or mobile application. Responses to the questions can be received by the 8010 patient survey service from the patient's medical device or account, accessed via the web or mobile app. These responses can then be transmitted to a 6040 cloud computing platform for advanced analysis. The cloud computing platform may include an analytics data lake containing data from a large number of other patients. Deep neural networks can be used to build models and analyze the received responses. In some instances, the 8010 patient survey service may queue the received responses for future analytical processing. The 8010 patient survey service can support the delivery of questions and / or answers to a remote patient monitoring system. Remote monitoring can be provided through a web or mobile application running on a remote external device (4286). Remote monitoring can provide a secure, cloud-based patient management system for online patient monitoring, enabling clinicians to quickly access patient data, share clinical knowledge with other healthcare professionals, and reduce costs associated with patient follow-up. Remote monitoring can receive information on medical device operation, compliance information, device settings, changes made to device settings, questions posed to the patient, and / or responses received from the patient.The clinician can use the data provided by remote monitoring to suggest new changes in training programs and / or in the patient's personalized therapy. The 8010 Patient Survey Service can receive coded initial questions from the medical device. Initial questions can be uploaded to the medical device during manufacturing. The medical device can present the initial questions and receive responses during setup or when a predetermined condition is met (for example, after the medical device has been used for a predetermined period or after a predetermined period has elapsed since setup). The initial questions can then be transmitted by the medical device to the 8010 Patient Survey Service for distribution to remote monitoring and / or the web or mobile application. In some cases, the initial questions may be available via the web or mobile application if they have not been answered on the medical device.The 8010 patient survey service can keep a record of the initial questions that have been answered. In some examples, the initial questions stored on the medical device may be provided separately to the 8010 patient survey service by the manufacturer. In this example, the 8010 patient survey service may receive the medical device identification (for example, the serial number) and the initial questions that have been stored on the medical device. 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ Initial questions stored on different medical devices may depend on the type of device and / or the features provided by the device. The 8030 patient portal can receive training content to provide the patient with instructions on how to use the device, how to improve device use, and / or how to achieve better results from the device. The training service may provide training content based on the results of an analysis of the patient's demographic and / or subjective feedback. 5.6.1 Oxygen supply In one form of the present technology, supplemental oxygen 4180 is supplied to one or more points in the pneumatic pathway, such as upstream to the pneumatic block 4020, to the air circuit 4170 and / or to the patient interface 3000. 5.7 HUMIDIFIER In one embodiment of this technology, a 5000 humidifier (e.g., as shown in Figure 5A) is provided to change the absolute humidity of the air or gas to be delivered to a patient relative to ambient air. Typically, the 5000 humidifier is used to increase the absolute humidity and temperature of the airflow (relative to ambient air) before it is delivered to the patient's airways. The humidifier 5000 may include a humidifier tank 5100, a humidifier inlet 5002 for receiving an airflow, and a humidifier outlet 5004 for supplying a humidified airflow. In some configurations, as shown in Figure 5A and Figure 5B, an inlet and an outlet of the humidifier tank 5100 may be the humidifier inlet 5002 and the humidifier outlet 5004, respectively. The humidifier 5000 may also include a humidifier base 5006, which can be adapted to receive a humidifier tank 5100 and a heating element 5240. According to one arrangement, the tank 5110 comprises a conductive portion 5120 configured to allow efficient heat transfer from the heating element 5240 to the liquid volume in the tank 5110, a humidification tank coupling 5130 (as shown in Figure 5B) configured to receive the humidification tank 5110 with a locking lever 5135 configured to retain the tank 5110 and / or a water level indicator 5150 (as shown in Figure 5A-5B), and / or one or more humidification transducers (sensors) 5210 instead of, or in addition to, the transducers 4270 described above. Humidifier transducers 5210 may include one or more of an air pressure sensor 5212, an air flow transducer 5214, a temperature sensor 5216, or a humidity sensor 5218 as shown in Figure 5C.A 5210 humidifier transducer can produce one or more output signals that can be communicated to a controller such as the 4230 central controller. 7ϠI I ϠϠ / 77Ϡ7 / □ / Yl· and / or the humidifier controller 5250. In some forms, a humidifier transducer can be located externally to the humidifier 5000 (as in the air circuit 4170) while communicating the output signal to the controller. According to a provision of the present technology, a humidifier 5000 may comprise a humidifier controller 5250 as shown in Figure 5C. In one embodiment, the humidifier controller 5250 may be part of the central controller 4230. In another embodiment, the humidifier controller 5250 may be a separate controller, which may be in communication with the central controller 4230. In one form, the 5250 humidifier controller can receive as inputs measured characteristics (such as temperature, humidity, pressure, and / or flow rate), for example, from the airflow, the water in the 5110 tank, and / or the 5000 humidifier. The 5250 humidifier controller can also be configured to run or implement humidification algorithms and / or supply one or more output signals. As shown in Figure 5C, the humidifier controller 5250 may comprise one or more controllers, such as a central humidifier controller 5251, a hot air circuit controller 5254 configured to control the temperature of a hot air circuit 4171, and / or a heating element controller 5252 configured to control the temperature of a heating element 5240. Examples of humidifier components are described in PCT application PCT / AU2014 / 050426 (WO2015089582), which is incorporated herein by reference. 5.8 RESPIRATORY PRESSURE THERAPY MODES The RPT 4000 device can implement various respiratory pressure therapy modes depending on the values ​​of parameters A and Po in the treatment pressure equation (Error! Reference source not found) used by the therapy parameter determination algorithm 4329 in a form of the present technology. 5.8.1 CPAP Therapy In some implementations of this form of the present technology, the amplitude A is identically zero; therefore, the treatment pressure Pi is identically equal to the baseline pressure Po throughout the respiratory cycle. Such implementations are generally grouped under the heading CPAP therapy. In such implementations, a therapy motor module 4320 is not required to determine the phase Φ or the waveform model Π(Φ). In step 4560, the central controller 4230 decreases the baseline pressure P0 by a decrement, provided that the decreased baseline pressure PO does not fall below a certain pressure. 7πI I π / 77π7 / □ / Yl· minimum treatment pressure Pmin. Method 4500 then returns to step 4520. In one implementation, the decrement is proportional to the value of P0-Pmin, so that the decrease of PO to the minimum treatment pressure Pmin in the absence of detected events is exponential. In one implementation, the proportionality constant is set so that the time constant τ of the exponential decrease of PO is 60 minutes, and the minimum treatment pressure Pmin is 4 cmH2O. In other implementations, the time constant τ could be as low as 1 minute and as high as 300 minutes, or as low as 5 minutes and as high as 180 minutes. In other embodiments, the minimum treatment pressure Pmin can be as low as 0 cmHLO and as high as 8 cmHLO, or as low as 2 cmHLO and as high as 6 cmH2O.Alternatively, the decrease in P0 could be predetermined, so that the decrease in PO to the minimum treatment pressure Pmin in the absence of detected events is linear. 5.8.2 Two-level therapy In other implementations of this form of current technology, the value of the amplitude A in the equation (Error! Reference source not found) can be positive. Such implementations are known as two-level therapy because, when determining the treatment pressure Pt using the equation (Error! Reference source not found) with a positive amplitude A, the therapy parameter determination algorithm 4329 oscillates the treatment pressure Pt between two values ​​or levels in sync with the patient's spontaneous respiratory effort 1000.That is, based on the waveform models Π(Φ, t) described above, the therapy parameter determination algorithm 4329 increases the treatment pressure Pt to Po + A (known as inspiratory positive pressure, IPAP) at the beginning of inspiration or during inspiration, and decreases the treatment pressure Pta to the baseline pressure Po (known as expiratory positive pressure, EPAP) at the beginning of expiration or during expiration. In some forms of bilevel therapy, IPAP is a prescribed treatment pressure that has the same target as the treatment pressure in CPAP therapy modes, and EPAP is IPAP minus amplitude A, which has a smaller value (a few cmH2O) sometimes referred to as expiratory pressure relief (EPR). Such forms are sometimes called CPAP with EPR, which is generally considered more comfortable than direct CPAP therapy. In CPAP with EPR, one or both of the IPAP and EPAP values ​​can be constant values ​​that are either coded or manually entered into the RPT 4000 device. Alternatively, the 4329 therapy parameter determination algorithm can continuously calculate IPAP and / or EPAP during CPAP with EPR.In this alternative, the therapy parameter determination algorithm 4329 continuously calculates EPAP and / or IPAP based on the indices or measurements of altered breathing during sleep returned by the respective algorithms in the therapy motor module 4320 in a manner analogous to the calculation of the base pressure Po in the APA therapy described above. 7ϠI I ϠΠ / 77Ϡ7 / □ / Yl· In other forms of two-level therapy, amplitude A is large enough that the RPT 4000 device performs some or all of the patient's work of breathing. In such forms, known as pressure support ventilation therapy, amplitude A is called pressure support, or oscillation. In pressure support ventilation therapy, Po plus pressure support A, and EPAP is the baseline pressure Po. In some forms of pressure support ventilation therapy, known as fixed pressure support ventilation therapy, pressure support A is set to a default value, for example, 10 cmH2O. The default pressure support value is a setting of the RPT 4000 device and can be set, for example, by physical coding during the RPT 4000 device setup or by manual input via the 4220 input device. In other forms of pressure-support ventilation therapy, widely known as servo-ventilation, the therapy parameter determination algorithm 4329 takes as input some currently measured or estimated respiratory cycle parameter (for example, the current measurement Vent of ventilation) and a target value for that respiratory parameter (for example, a target value Vtgt of ventilation) and repeatedly adjusts the equation parameters (Error! Reference source not found) to bring the current measurement of the respiratory parameter closer to the target value. In a form of servo-ventilation known as adaptive servo-ventilation (ASV), which has been used to treat ROS, the target ventilation Vtgt is calculated by the target ventilation determination algorithm 4328 from the recent typical ventilation Vtyp, as described above. In some forms of servoventilation, the therapy parameter determination algorithm 4329 applies a control methodology to continuously calculate pressure support A so that the current measured ventilation (Vti) approaches the target ventilation. One such control methodology is proportional-integral (Pl) control. In an implementation of Pl control, suitable for ASV modes in which a target ventilation (Vtg) is set to a value slightly lower than the recent typical ventilation (Vty), the pressure support is calculated as: A = G j (Vent -Vtgtjdt where G is the gain of the Pl control. Larger values ​​of gain G can result in positive feedback in the 4320 therapy motor module. Smaller values ​​of gain G can allow untreated residual CSR or central sleep apnea. In some implementations, gain G is fixed at a default value, such as -0.4 cmH2O / (L / min) / second. Alternatively, gain G can vary between therapy sessions, starting gradually and increasing session by session until a value is reached that almost eliminates CSR. In these implementations, conventional means can be used to retrospectively analyze the parameters of a therapy session to assess the severity of CSR during the therapy session. In other implementations, gain G can vary based on the difference between the current measured ventilation (Vent) and the target ventilation (Vtgt). Other servoventilation control methodologies that can be applied by the therapy parameter determination algorithm 4329 include proportional (P), proportional-differential (PD), and proportional-integral-differential (PID). The pressure support value A calculated using equation () can be clipped to a range defined as [Amin, Amax]. In this implementation, pressure support A defaults to the minimum pressure support Amin until the current ventilation measurement Vent falls below the target ventilation Vtgt, at which point A begins to increase and only returns to Amin when Vent exceeds Vtgt once again. The Amin and Amax pressure support limits are RPT 4000 device settings, established for example by physical coding during RPT 4000 device setup or by manual seating via the 4220 input device. In pressure support ventilation therapy modes, EPAP is the baseline pressure (Po). As with the baseline pressure (Po) in CPAP therapy, EPAP can be a constant value that is prescribed or determined during titration. Such a constant EPAP can be set, for example, by physical coding during the setup of the RPT 4000 device or by manual setting via the 4220 input device. This alternative is sometimes referred to as fixed EPAP pressure support ventilation therapy. A clinician can titrate the EPAP for a given patient during a titration session using polysomnography (PSG) to prevent obstructive apneas, thereby maintaining an open airway for pressure support ventilation therapy, similar to titrating the baseline pressure (Po) in constant CPAP therapy. Alternatively, the therapy parameter determination algorithm 4329 can continuously calculate the baseline pressure Po during pressure support ventilation therapy. In these implementations, the therapy parameter determination algorithm 4329 continuously calculates EPAP as a function of the indices or measures of disturbed sleep breathing returned by the respective algorithms in the therapy engine module 4320, such as one or more of flow limitation, apnea, hypopnea, airway permeability, and snoring. Because the continuous calculation of EPAP resembles a clinician's manual adjustment of EPAP during EPAP titration, this process is also known as EPAP auto-titration, and the overall therapy is referred to as self-titrating EPAP pressure support ventilation therapy, or autoEPAP pressure support ventilation therapy. 7ϠI I ϠΠ / 77Ϡ7 / □ / Yl· 5.9 GLOSSARY For the purposes of this technology disclosure, one or more of the following definitions may apply to certain forms of this technology. Alternative definitions may apply to other forms of the current technology. 5.9.1 General Air: In certain forms of the present technology, air may be taken as atmospheric air, and in other forms of the present technology, air may be taken as another combination of breathable gases, e.g., atmospheric air enriched with oxygen. Environment: In certain forms of the present technology, the term environment shall be understood as (i) external to the treatment system or the patient, and (ii) immediately surrounding the treatment system or the patient. For example, the ambient humidity relative to a humidifier might be the humidity of the air surrounding the humidifier, such as the humidity in the room where a patient is sleeping. This ambient humidity might differ from the humidity outside the room where the patient is sleeping. In another example, ambient pressure can be the pressure that immediately surrounds the body or is external to the body. In some ways, ambient noise (e.g., acoustic) can be considered the background noise level in the room where the patient is located, for example, noise generated by a chest X-ray device or emanating from a mask or patient interface. Ambient noise can also originate from sources outside the room. Automatic positive airway pressure therapy (APAR): CPAP therapy in which the treatment pressure is automatically adjusted, e.g., breath by breath, between the minimum and maximum limits, depending on the presence or absence of indications of respiratory distress syndrome (RDS) events. Continuous positive airway pressure (CPAP) therapy: Respiratory pressure therapy in which the treatment pressure is approximately constant throughout a patient's respiratory cycle. In some forms, the pressure at the airway inlet will be slightly higher during exhalation and slightly lower during inhalation. In other forms, the pressure will vary between different respiratory cycles of the patient, for example, increasing in response to the detection of indications of partial upper airway obstruction and decreasing in the absence of indications of partial upper airway obstruction. 7ϠI I ϠΠ / 77Ϡ7 / □ / Yl· Flow rate: The instantaneous volume (or mass) of air supplied per unit of time. Flow rate can refer to an instantaneous quantity. In some cases, a reference to flow rate will be a reference to a scalar quantity, namely, a quantity that only has magnitude. In other cases, a reference to flow rate will be a reference to a vector quantity, namely, a quantity that has both magnitude and direction. Flow rate may be represented by the symbol Q. Flow rate can be shortened to airflow or air volume. In the patient breathing example, a flow rate can be nominally positive for the inspiratory portion of a patient's respiratory cycle and therefore negative for the expiratory portion. The total flow rate, Qt, is the airflow exiting the respiratory support device. The ventilation flow rate, Qv, is the airflow delivered during a ventilation to allow for the removal of exhaled gases. The leakage flow rate, Ql, is the leakage flow rate from a patient interface system or other device. The respiratory flow rate, Qr, is the airflow received by the patient's respiratory system. Humidifier. The word humidifier shall have the meaning of a humidifying apparatus constructed and arranged, or configured with a physical structure to be able to provide a therapeutically beneficial amount of water vapor (H2O) to an airflow to improve a patient's medical respiratory condition. Leak: The term "leak" will be interpreted as an unintentional flow of air. For example, a leak might occur as a result of an incomplete seal between the mask and a patient's face. Another example might be a leak from a swivel elbow into the environment. Conducted (acoustic) noise: Conducted noise in this document refers to noise that reaches the patient through the pneumatic pathway, such as the air circuit and patient interface, as well as the air within them. Conducted noise can be quantified by measuring sound pressure levels at the end of an air circuit. Radiated noise (acoustic): Radiated noise in this document refers to noise that reaches the patient through the ambient air. In one way, radiated noise can be quantified by measuring the sound power / sound pressure levels of the object in question in accordance with ISO 3744. Noise, ventilation (acoustic): Ventilation noise in this document refers to noise that is generated by the flow of air through vents such as ventilation holes at the patient interface. Patient: A person, who may or may not suffer from a respiratory condition. Pressure: Force per unit area. Pressure can be expressed in a range of units including cmH2O, gf / cm2, and hectopascals. 1 cmH2O is equal to 1 gf / cm2 and is approximately 0.98 hectopascals. 7ϠI I ϠΠ / 77Ϡ7 / □ / Yl· In this descriptive report, unless otherwise stated, pressure is given in units of cmH2O. The pressure at the patient interface is given by the symbol Pm, while the treatment pressure, which represents a target value that the mask pressure Pm should reach at a given time, is given by the symbol Pt. Respiratory Pressure Therapy (RPT): The application of an air supply into an airway inlet at a treatment pressure that is typically positive relative to the atmosphere. Ventilator. A mechanical device that provides pressure support to a patient to perform all or part of the work of breathing. 5.9.2 Respiratory cycle Apnea: According to some definitions, apnea occurs when airflow falls below a predetermined threshold for a period of time, e.g., 10 seconds. Obstructive apnea occurs when, despite the patient's effort, some airway obstruction prevents airflow. Central apnea occurs when apnea is detected due to a reduction in respiratory effort or the absence of respiratory effort, even though the airway is patent. Mixed apnea occurs when a reduction or absence of respiratory effort coincides with an obstructed airway. Respiratory rate: The rate of a patient's spontaneous breathing, usually measured in breaths per minute. Duty cycle: The relationship between inhalation time, Ti and total breathing time, Ttot. Effort (breathing): The work done by a person breathing spontaneously in an attempt to breathe. Expiratory portion of the respiratory cycle: The period from the beginning of the expiratory flow rate to the beginning of the inspiratory flow rate. Flow limitation: Flow limitation is defined as the situation in a patient's breathing where an increase in the patient's effort does not result in a corresponding increase in flow rate. When flow limitation occurs during an inspiratory portion of the respiratory cycle, it can be described as inspiratory flow limitation. When flow limitation occurs during an expiratory portion of the respiratory cycle, it can be described as expiratory flow limitation. 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ Flow-limited types of inspiratory waveforms: (i) Flat. It has a rise followed by a relatively flat portion followed by a fall. (i) M-shaped: It has two local peaks, one on the leading edge and one on the lower edge, and a relatively flat portion between the two peaks. (iii) Seat-shaped: It has a single local peak, which is located on the main edge, followed by a relatively flat portion. (iv) In reverse seat form: It has a relatively flat portion followed by a local single peak, where the peak is located on the lower edge. Hypopnea: According to some definitions, hypopnea is considered a reduction in airflow, but not a complete cessation of flow. In one sense, hypopnea occurs when there is a reduction in airflow below a threshold velocity for a period of time. Hypopnea also occurs when hypopnea is detected due to a reduction in respiratory effort. In adults, any of the following would be considered hypopnea: (i) a 30% reduction in the patient's respiration for at least 10 seconds plus an associated 4% desaturation; or (ii) a reduction in the patient's respiration (but less than 50%) for at least 10 seconds with an associated desaturation of at least 3% or stimulation. Hyperpnea: An increase in airflow to a level greater than normal. Inspiratory portion of the respiratory cycle: The period from the beginning of the inspiratory flow to the beginning of the expiratory flow will be considered the inspiratory portion of a respiratory cycle. Airway patency: The degree of airway openness, or the degree to which the airway is open. A patent airway is open. Airway patency can be quantified, for example, with a value of one (1) meaning patent, and a value of zero (0) meaning closed (obstructed). Positive end-expiratory pressure (PEEP): The pressure above the atmosphere in the lungs that exists at the end of expiration. Peak flow rate (Qpeak): The maximum flow rate value during the inspiratory portion of the respiratory flow waveform. 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ Respiratory flow, patient airflow, respiratory airflow (Qr): These terms can be understood to refer to an estimate by the RPT device of respiratory airflow, as opposed to true respiratory flow which is the actual respiratory flow experienced by the patient, usually expressed in liters per minute. Tidal volume (Vt): The volume of air inhaled or exhaled during normal breathing, when no additional effort is applied. In principle, the inspiratory volume Vi (the volume of air inhaled) is equal to the expiratory volume Ve (the volume of air exhaled), and therefore, a single tidal volume Vt can be defined as any value. In practice, the estimated tidal volume Vtes is a certain combination, e.g., the average, of the inspiratory volume Vi and the expiratory volume Ve. Time (of inhalation) (Ti): The duration of the inspiratory portion of the respiratory flow waveform. Time (of exhalation) (Te): The duration of the expiratory portion of the respiratory flow waveform. Time (total) (Ttot): The total duration between the beginning of the inspiratory portion of one respiratory flow waveform and the beginning of the inspiratory portion of the next respiratory flow waveform. Typical recent ventilation: The ventilation value around which recent ventilation values ​​(Vent) over a predetermined time scale tend to cluster, i.e., a measure of the central tendency of recent ventilation values. Upper airway obstruction (UAO): This includes partial and complete obstruction of the upper airway. This may be associated with a flow-limiting state, where flow barely increases or may even decrease as the pressure difference in the upper airway increases (Starling resistance behavior). Ventilation (Vent): A measurement of the rate of gas exchanged by the patient's respiratory system. Ventilation measurements may include inspiratory and / or expiratory flow rates per unit of time. When expressed as a volume per minute, this quantity is usually referred to as minute ventilation. Minute ventilation is sometimes given simply as a volume, and it is understood to be a volume per minute. 5.10 OTHER COMMENTS A portion of the disclosure in this patent document contains material that is subject to intellectual property protection. The copyright holder has no objection to its reproduction. 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ facsimile of the document or patent disclosure by any person, as it appears in the patent files or records of the Patent Office, but reserves all corresponding copyright. Unless the context clearly indicates otherwise, and where a range of values ​​is provided, it is understood that each intermediate value, to one-tenth of the lower limit, between the upper and lower limits of that range, and any other declared or intermediate value within the defined range, is included within the technology. The upper and lower limits of these intermediate ranges, which may be independently included within the intermediate ranges, are also included within the technology, subject to any limits specifically excluded within the declared range. Where the declared range includes one or both limits, the ranges that include either or both of these included limits are also included in the technology. Furthermore, where one or more values ​​are indicated as implemented as part of the technology, it is understood that such values ​​may be approximate, unless otherwise indicated, and such values ​​may be used in any significant digit to the extent that practical technical implementation permits or requires. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by someone skilled in the art to which the technology belongs. Although any method and material similar or equivalent to those described herein may also be used in the practice or testing of this technology, this document describes a limited number of exemplary methods and materials. When a particular material is identified as being used to construct a component, obvious alternative materials with similar properties may be used as a substitute. Furthermore, unless otherwise specified, it is understood that all components described herein are capable of being manufactured and, as such, may be manufactured together or separately. It should be noted that, as used herein and in the accompanying claims, the singular forms a, an and the include their plural equivalents, unless the context clearly indicates otherwise. All publications mentioned herein are incorporated herein by reference in their entirety to disclose and describe the methods and / or materials that are the subject of those publications. The publications discussed herein are provided solely for disclosure prior to the filing date of this application. Nothing in this document should be construed as an admission that the disclosed technology is not entitled to predate such application. 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ publication under the prior invention. Furthermore, the publication dates provided may differ from the actual publication dates, which may require independent confirmation. The terms comprise and comprise should be interpreted as referring to elements, components, or steps in a non-exclusive manner, indicating that the elements, components, or steps being referenced may be present, or used, or combined with other elements, components, or steps that are not expressly referenced. The headings used in the detailed description are included only to facilitate the reader's reference and should not be used to limit the subject matter found throughout the disclosure or claims. The headings should not be used to interpret the scope of the claims or their limitations. Although the technology presented has been described with reference to specific examples, it should be understood that these examples are merely illustrative of the technology's principles and applications. In some cases, the terminology and symbols may imply specific details that are not required to practice the technology. For example, while the terms "first" and "second" may be used, unless otherwise specified, they are not intended to indicate any order but may be used to distinguish between different elements. Furthermore, while the process steps in methodologies may be described or illustrated in a particular order, such an order is not required. Those knowledgeable in the subject will recognize that such an ordering may be modified and / or its aspects may be performed concurrently or even synchronously. Therefore, it should be understood that numerous modifications can be made to the illustrative examples and that other arrangements can be designed without departing from the spirit and scope of the technology. 5.11 LIST OF REFERENCE SIGNS 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ patient 1000 another patient 1002 another patient 1004 bedmate 1100 patient interface 3000 RPT device 4000 outer casing 4010 upper portion 4012 portion 4014 panel(s) 4015 chassis 4016 handle 4018 4020 pneumatic block 4110 air filter 4112 inlet air filter 4114 outlet air filter 4120 silencer 4122 inlet filter 4124 outlet filter 4140 pressure generator 4140 blower 4142 motor 4144 anti-spill return valve 4160 air circuit 4170 air circuit 4171 supplemental oxygen 4180 electrical components 4200 single printed circuit board assembly 4202 power supply 4210 input device 4220 central controller 4230 clock 4232 therapy device controller 4240 protection circuits 4250 memory 4260 transducer 4270 pressure sensor 4272 flow sensor 4274 speed sensor 4276 data communication interface 4280 remote external communication network 4282 external local communication network 4284 4286 remote external device 4288 local external device 4290 output device 4292 display controller 4294 display 4300 algorithms 4310 preprocessing module 7ϠI I Ϡη / 77Γ>7 / 3 / Y Pressure compensation algorithm 4312 Ventilation flow rate estimation 4314 Leakage flow rate estimation 4316 Leakage flow rate estimation 4316 Respiratory flow rate estimation 4318 Therapy engine module 4320 Phase determination algorithm 4321 Waveform determination algorithm 4322 Ventilation determination algorithm 4323 Inspiratory flow rate limitation determination algorithm 4324 Apnea / hypopnea determination algorithm 4325 Snoring determination algorithm 4326 Snoring determination algorithm 4326 Snoring determination algorithms 4326 Nasal patency determination algorithm 4327 Target ventilation determination algorithm 4328 Therapy parameter determination algorithm 4329 Therapy control module 4330 Algorithms 4340 Method 4500 Step 4520 Step 4560 Humidifier 5000 Humidifier inlet 5002 Humidifier outlet 5004 Humidifier base5006 Humidifier, 5110 Reservoir, 5120 Conductive Portion, 5130 Humidifier Reservoir Spring, 5135 Locking Lever, 5150 Water Level Indicator, 5210 Humidifier Transducer, 5212 Pressure Transducers, 5214 Flow Transducers, 5216 Temperature Transducers ζπί Lnn / zznz / q / Yi 5218 humidity sensor 5240 heating element 5250 humidifier controller 5251 central humidifier control 5252 heating element controller 5254 air circuit controller 5286 remote external device 6020 communication link 6030 server 6040 cloud computing platform 6062 medical devices 6064 configuration step 7010 step 7012 step 7014 step 7016 step 7018 step 7020 step 7022 step 7024 step 7026 step 7028 step 7030 step 7032 step 7034 step 7036 display screen 7050 display screen 7052 display screen 7054 display screen 7056 display screen 7058 display screen 7060 display screen 7062 display screen 7064 visualization, 8010 patient survey service, 8020 patient survey service, 8024 MCS device 7ΠΙ I ηη / 77Π7 / 3 / Υ patient portal

Claims

1. A respiratory pressure therapy system for providing continuous positive airway pressure (CPAP) to a patient using an apparatus, the system comprising: a flow generator configured to generate the breathable gas supply for delivery to the patient, wherein the breathable gas leaves the flow generator at a pressure level that is above atmospheric pressure; at least one sensor configured to measure a physical quantity while the breathable gas is being delivered to the patient; a computing device including memory and at least one hardware processor, the computing device configured to: perform the configuration of the apparatus prior to the initial use of the respiratory pressure therapy system by the patient, the configuration of the apparatus including the association of the apparatus with the patient and the configuration of the apparatus control settings based on the responses entered by the patient;receive, from at least one sensor, sensor data that is based on the measured physical property of the breathing gas supply; control, based on the data received from the sensor, the flow generator to adjust a property of the breathing gas supply delivered to the patient and the control settings of the device; and after a preset amount of time has elapsed after the device has been set up and / or after a predetermined condition relating to the use of the device by the patient has been met: display, on a display device, one or more questions relating to demographic feedback and selectable answers to the one or more questions relating to demographic feedback and one or more questions relating to subjective feedback and a selectable variable scale to provide an answer to the one or more questions relating to subjective feedback;In response to the display of one or more questions, receive one or more user inputs to the selectable responses indicating the answers to one or more questions related to demographic feedback and one or more user inputs to the variable scale indicating the answers to one or more questions related to subjective feedback; transmit the responses to the one or more questions relating to demographic feedback and the responses to the one or more questions relating to subjective feedback to a remote processing system; receive, from the remote processing system, the respiratory pressure therapy system settings determined based on the transmitted responses; and adjust, based on the received settings, the respiratory pressure therapy system control settings established during device configuration.

2. The respiratory pressure therapy system of claim 1, wherein the remote processing system is an on-demand cloud computing platform configured to perform machine learning using data received from a plurality of patients.

3. The respiratory pressure therapy system of claims 1 or 2, wherein questions relating to demographic feedback and subjective feedback are pre-stored in memory.

4. The respiratory pressure therapy system of any of claims 1 to 3, wherein one or more questions relating to demographic feedback and subjective feedback are received from the remote processing system.

5. The respiratory pressure therapy system of any of claims 1 to 4 further comprises a patient interface configured to couple with at least one patient airway and to supply breathable gas to the patient.

6. The respiratory pressure therapy system of any of claims 1 to 5, wherein the questions include at least one question relating to the patient's demographic information and at least one question relating to the patient's subjective opinion on the use of the respiratory pressure therapy system.

7. The respiratory pressure therapy system of any of claims 1 to 6 further comprises the remote processing system, and the remote processing system is configured to determine customized training programs for the patient based on the responses transmitted to the remote processing system.

8. The respiratory pressure therapy system of any of claims 1 to 6 further comprises the remote processing system and the remote processing system is configured to determine a personalized therapy for the patient based on the responses transmitted to the remote processing system.

9. The respiratory pressure therapy system of any of claims 1 to 8, wherein the computer device is further configured during apparatus setup to: display, on the display device, an additional question relating to demographic feedback and a selectable answer to the additional question relating to demographic feedback and an additional question relating to subjective feedback and a selectable answer to the additional question relating to subjective feedback; in response to the display of one or more additional questions, receive user inputs to the selectable answers indicating the responses to the additional questions relating to demographic feedback and subjective feedback; transmit the responses to the additional questions to the remote processing system;to receive, from the remote processing system, the respiratory pressure therapy system settings determined based on the transmitted responses; and to establish, based on the received settings, the respiratory pressure therapy system control settings established during device configuration. 7PI I PI / 77PI / □ / Yl·; 10. The respiratory pressure therapy system of claim 9, wherein the default condition includes the patient using the device for a predetermined amount of time.

11. The respiratory pressure therapy system of any of claims 1 to 9, wherein the settings of the respiratory pressure therapy system and / or the customized training programs are received via an application, website, email and / or a patient-associated mobile device.

12. An apparatus for treating a respiratory disorder in a patient, the apparatus comprising: a display device; a pressure generator configured to generate an airflow to treat the respiratory disorder; a transducer configured to generate a flow signal representing a property of the airflow; a controller, coupled to the display, the pressure generator, and the transducer, the controller being configured to: perform the configuration of the apparatus prior to initial use by the patient, the configuration of the apparatus including associating the apparatus with the patient and configuring the control settings of the apparatus based on the responses entered by the patient; receive the flow signal from the transducer; based on the received flow signal and the control settings of the apparatus, control the pressure generator to adjust a property of the airflow;and after a predetermined amount of time has elapsed after the device has been set up and / or after a predetermined condition relating to the patient's use of the device has been met: display, on the display device, a request for demographic feedback and selectable responses to the demographic feedback request and a request for subjective feedback and a selectable variable scale to provide a response to the subjective feedback request; in response to the demographic feedback request, receive one or more inputs to the selectable responses representing demographic feedback; in response to the subjective feedback request, receive one or more inputs to the variable scale representing subjective feedback;To transmit to a remote processing system the demographic and subjective feedback data determined on the basis of one or more received inputs; to receive, from the remote processing system, analysis results determined on the basis of the transmitted demographic and subjective feedback data; and to adjust, based on the received analysis results, the device control settings established during device configuration. 7Π L ίΠΠ / 77Π7 / 3 / ΥΙ; 13. The apparatus of claim 12, wherein the controller, display and pressure generator are housed in common.

14. The apparatus of claim 12 or 13, wherein the adjusted control configuration includes a treatment pressure delivered to a patient mask coupled to the pressure generator.

15. The apparatus of any of claims 12 to 14, wherein the controller is configured to transmit, with demographic and subjective feedback data, operational data of the apparatus, and the results of the analysis are determined on the basis of the demographic and subjective feedback data and the operational data of the apparatus.

16. The apparatus of any of claims 12 to 15, wherein the results of the analysis include a personalized training program for the patient.

17. The apparatus of any of claims 12 to 16, wherein the results of the analysis include a personalized therapy for the patient.

18. A method of operating a respiratory treatment device to generate an airflow for the purpose of treating a respiratory disorder, the method comprising: performing, by means of a controller, the configuration of the device prior to the initial use of the respiratory treatment device by a patient, the configuration of the device including, the configuration of the device includes, the association of the device with the patient and the configuration of the device control settings based on the responses entered by the patient; measuring a property of the airflow, by means of a transducer; calculating, in the controller and based on the measured property, a result comprising at least one of: a respiratory event, a cardiorespiratory characteristic of a patient and a physiological state of the patient; controlling, in the controller, an adjustment of a property of the airflow based on the result and the device control settings;and after a predetermined amount of time has elapsed after the device has been set up and / or after a predetermined condition relating to the patient's use of the device has been met: display one or more questions relating to demographic feedback and selectable answers to the one or more questions relating to demographic feedback and one or more questions relating to subjective feedback and a selectable variable scale to provide an answer to the one or more questions relating to subjective feedback; in response to the display of one or more questions, receive, in the controller, one or more user inputs to the selectable answers indicating the answers to one or more questions relating to demographic feedback and one or more user inputs to the variable scale indicating the answers to one or more questions relating to subjective feedback;transmit the responses to one or more questions relating to demographic feedback and the responses to one or more questions relating to subjective feedback to a remote processing system; and receive, from the remote processing system, adjustments for the operation of the respiratory treatment device and personalized training programs for the patient based on the responses transmitted to the remote processing system.

19. The method of claim 18 further comprises adjusting, based on the adjustments received, the control of the respiratory treatment apparatus established during the configuration of the apparatus.

20. The method of claim 18 or 19, wherein the settings for the operation of the respiratory treatment apparatus provide personalized therapy for the patient determined on the basis of the responses transmitted to the remote processing system and the control settings of the respiratory treatment apparatus at the time the inputs indicating the responses are received.

21. The method of any of claims 18 to 20, wherein the questions are displayed on a screen of the respiratory treatment apparatus.

22. The method of any of claims 18 to 20, wherein the questions are displayed on a mobile device configured to run an application to control the respiratory treatment apparatus.

23. The method of any of claims 18 to 22, wherein the predetermined condition includes the patient achieving a specified goal in relation to the use of the apparatus.

24. The method of claim 23, wherein the predetermined condition includes a predetermined period of time in which the respiratory treatment apparatus has been operated by the patient.

25. A processing system comprising: a memory that stores a plurality of demographic questions and a plurality of objective questions; a computer system that includes at least one hardware processor coupled to the memory, the computer system being configured to: transmit, to a medical device associated with a patient, at least one demographic question and at least one objective question stored in the memory; receive, from the medical device, the answers to the at least one demographic question and at least one objective question transmitted to the medical device; transmit, to a mobile device configured to run an application to communicate with the medical device, a notification indicating that there are unanswered questions; receive, from the mobile device, a request for the questions;In response to the request, transmit to the mobile device at least one demographic question and at least one objective question stored in memory; receive from the mobile device the responses to the at least one demographic question and the at least one objective question transmitted to the mobile device; and perform analyses to determine, based on (1) the responses received from the medical device and the mobile device and (2) the responses received from a plurality of other medical devices, a tailored training program for the patient and personalized therapy using the medical device.

26. The processing system of claim 25, wherein the medical device is a respiratory treatment apparatus.

27. The processing system of claim 25 or 26, wherein the computer system is further configured to receive, from the medical device, the answers to the questions pre-stored in the medical device and answered by means of the medical device.

28. The processing system of any of claims 25 to 27, wherein the questions are transmitted to the mobile device and / or the medical device after a predetermined condition is met.

29. The processing system of claim 28, wherein the default condition is a predetermined time period after the medical device has been set up and / or a predetermined time period in which the medical device has been operated by the patient.

Images